Breakthrough treatment for severe PTSD in the form of a psychedelic stimulant

This landmark study reports on the outcomes of a trial in persons suffering from severe PTSD.

Educational Objectives

Educational Aim:
The aim of this article is to assess the efficacy and safety of MDMA-assisted therapy in individuals with severe PTSD.

Editor's comments:
PTSD is a debilitating condition with a high morbidity and mortality. In South Africa, PTSD is common because of high levels of crime and interpersonal violence, including gender-based violence. The condition is difficult to treat and novel therapies such as psychedelics show promise in terms of efficacy, safety and cost for management of this condition.

Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:

1. The potential for the use of MDMA-assisted therapy for people with severe PTSD.

2. The potential for the use of MDMA-assisted therapy for people with severe PTSD and comorbidities.

Instructions for this Module

• Read the supplied reading material and complete the quiz that follows;
• You have three attempts to pass the quiz;
• The pass grade is 70%;
• You need to pass the quiz to claim your CPD certificate;
• Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.

If you need any assistance to complete this module, please Contact us